Pyridam Farma Tbk PT
IDX:PYFA

Watchlist Manager
Pyridam Farma Tbk PT Logo
Pyridam Farma Tbk PT
IDX:PYFA
Watchlist
Price: 515 IDR -2.83%
Market Cap: 5.8T IDR

Relative Value

The Relative Value of one PYFA stock under the Base Case scenario is hidden IDR. Compared to the current market price of 515 IDR, Pyridam Farma Tbk PT is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PYFA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
26
vs Industry
62
Median 3Y
1.6
Median 5Y
1.4
Industry
2.6
vs History
vs Industry
43
Median 3Y
-7.6
Median 5Y
1.4
Industry
21.6
vs History
vs Industry
22
Median 3Y
-2.5
Median 5Y
-4.8
Industry
16.5
vs History
vs Industry
36
Median 3Y
1.2
Median 5Y
1.6
Industry
22.5
vs History
6
vs Industry
46
Median 3Y
2.5
Median 5Y
3.2
Industry
2.3
vs History
31
vs Industry
31
Median 3Y
3.6
Median 5Y
2
Industry
2.9
vs History
11
vs Industry
15
Median 3Y
10.5
Median 5Y
5.4
Industry
5.5
vs History
vs Industry
0
Median 3Y
-47.3
Median 5Y
9.2
Industry
13
vs History
vs Industry
0
Median 3Y
-47.3
Median 5Y
9.2
Industry
16.6
vs History
vs Industry
8
Median 3Y
-10.5
Median 5Y
-12.3
Industry
15.8
vs History
vs Industry
7
Median 3Y
-12.3
Median 5Y
-12.3
Industry
19.1
vs History
44
vs Industry
57
Median 3Y
1.1
Median 5Y
1.4
Industry
1.9

Multiples Across Competitors

PYFA Competitors Multiples
Pyridam Farma Tbk PT Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ID
Pyridam Farma Tbk PT
IDX:PYFA
5.8T IDR 2.1 -12 -69.4 -69.4
US
Eli Lilly and Co
NYSE:LLY
1T USD 16.9 54.6 36.6 39.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
515.3B USD 5.6 20.5 16.8 21.7
CH
Roche Holding AG
SIX:ROG
256.3B CHF 4.2 27.2 11.6 13.6
UK
AstraZeneca PLC
LSE:AZN
211.1B GBP 4.9 30 108.3 158.4
CH
Novartis AG
SIX:NOVN
205.8B CHF 4.6 18 11.4 14.7
US
Merck & Co Inc
NYSE:MRK
249.4B USD 3.9 13.1 9.3 11.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.5 13.5 9.5 11
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
150.3B USD 2.4 15.3 7.7 10.5
P/E Multiple
Earnings Growth PEG
ID
Pyridam Farma Tbk PT
IDX:PYFA
Average P/E: 24
Negative Multiple: -12
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.6
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.5
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.2
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30
38%
0.8
CH
Novartis AG
SIX:NOVN
18
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.1
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.5
4%
3.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
15.3
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
ID
Pyridam Farma Tbk PT
IDX:PYFA
Average EV/EBITDA: 438.9
Negative Multiple: -69.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.6
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.8
9%
1.9
CH
Roche Holding AG
SIX:ROG
11.6
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
CH
Novartis AG
SIX:NOVN
11.4
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.3
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.5
2%
4.7
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.7
1%
7.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
ID
Pyridam Farma Tbk PT
IDX:PYFA
Average EV/EBIT: 1 881.3
Negative Multiple: -69.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.2
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.7
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.6
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.4
23%
6.9
CH
Novartis AG
SIX:NOVN
14.7
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.1
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11
1%
11
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.5
8%
1.3